The Use of Probiotics in the Primary Prevention of Atopic Dermatitis: A Systemic Review of the Literature in Light of the Hygiene Hypothesis by Leisegang, Kristian et al.
The Use of Probiotics in the Primary Prevention of Atopic Dermatitis:
A Systemic Review of the Literature in Light of the Hygiene 
Hypothesis
Carmen van der Linde, Xu Wang, Kristian Leisegang
School of Natural Medicine, University of the Western Cape, Bellville, South Africa
INTRODUCTION:
Atopic dermatitis (eczema) is a type 1 hypersensitivity reaction that is common in infants and
young children, with incidence increasing in the Industrialised world. Based on epidemiological
evidence, the hygiene hypothesis proposes that reduced exposure to infective organisms is
associated with immune dysfunction (Seroni et al., 2010). Caesarean sections, lack of breast
feeding, lack of exposure to micro-organisms and parasites in early life, widespread use of
antibiotics and a more hygienic or clean environment is closely associated with the development
of atopic dermatitis. This is explained by type 2 helper T-lymphocyte (Th2) cell dominance and a
reduction in T-regulatory (Treg) cell function due to lack of stimulation via infectious organisms
(Boon et al., 2006; Seroni et al., 2010) (Fig. 1). Furthermore, altered gut microbiota and dysbiosis
due to similar risk factors has been implicated in the development of atopic dermatitis (Kranich et
al, 2011). There has been recent interest in the use of probiotics in the prevention of atopic
dermatitis. The terms atopic dermatitis and atopy are incorrectly used interchangeable in much
of the literature, and this study will follow this protocol.
METHODS:
Electronic research databases were systematically searched using relevant keywords. Articles
were limited to randomised, double blind placebo controlled papers that specify the probiotic
strains, the dosages and protocols used.
CONCLUSIONS:
Based on the studies identified, Lactobacillus rhamnosus supplemented to pregnant mothers and to infants from birth to 6 months in dosages from 5 to 10
billion colony forming units (cfu) per day has shown the most beneficial results in primary prevention of atopic dermatitis in infants. Pre-natal supplementation
shows little benefit and should not be recommended. Numerous studies showed a reduction in incidence of eczema, but not necessarily atopy and IgE
sensitisation. It is therefore difficult to determine if any positive impact is based on the hygiene hypothesis in terms of allergic disease, although West (2009)
showed benefit based on this model. It is recommended that future studies focus on larger trials to refine a beneficial protocol for prevention. Furthermore,
studies should include the impact of the supplementation on the microbiota of the infants, and the possible mechanisms of benefits based on the hygiene
hypothesis model.
Table 1: A comparison of placebo controlled studies assessing the efficacy of probiotics in the prevention of atopic dermatitis (eczema). The studies identified 






Vaginal birth & Breast feeding
Presence of older siblings
Less antibiotic use
Rural environment





Caesarian birth and bottle feeding
Small families

























112 4-6 wk 6 mo. 
(mother)
1 yr Some benefit in high risk infants;
No difference in IgE levels of food allergen sensitisation
Kim et al., 2009
Lactobacillus F19 1 x 108 179 Nil 13 mo. 
(infant)
13 mo. Decreased incidence of eczema
Increased Th1/Th2 ratio; No difference in serum IgE
West et al., 2009
Lactobacillus acidophilus 3 x 109 231 Nil 6 mo. 
(infant)
2 yr No benefit Taylor et al., 
2007
Lactobacillus rhamnosus 5 x 109 154 Nil 1 mo. 1 mo. Study showed improvement of IgE associated atopic 
eczema in a treatment design  (not prevention)
Viljanen et al., 
2005
Lactobacillus reuteri 1 x 108 188 4 wk 12 mo. 
(infant)
2 yr No difference in incidence or severity











1223 2-4 wk 6 mo. 
(infant)
2 yr Decreased incidence of  atopic eczema and IgE
associated disease
No effect on all types of allergic disease
Lacto- and bifidobacteria more frequently colonised infants








156 6 wk 12 mo. 
(infant)
2 yr Decreased incidence of eczema
Lactococcus more frequently colonised infants





474 5 wk 24 mo.
(infant)
2 yr Decreased incidence with L. Rhamnosus, but not with B. 
Animalis for eczeman, but not atopy








415 4 wk 3 mo. 2 yr Decreased incidence of atopic eczema; 
No difference in  atopic sensitisation or asthma
Dotterud et al., 
2010
Lactobacillus rhamnosus 2 x 1010 159 2-4 wk 6 mo. 2, 4 & 7 
yr
Decreased incidence with no difference in severity;
No difference in atopic sensitisation
Kalliomaki et al., 
2007
Lactobacillus rhamnosus 1 x 1010 105 4-6 wk 6 mo. 2 yr No difference in incidence or severity; 
Associated with increased rates of bronchial wheezing
Kopp 2et al., 
2008
RESULTS
In total, 12 studies were identified. Of these, 2 studies utilised pre-natal exposure only, 3 studies
utilised post-natal administration to infants, and 7 studies that administered probiotics both pre-
and post-natally. The probiotic strain, dosage and time of intervention varied greatly, as did the
results. The results are summarised in table 1.
Figure 1: The hygiene hypothesis is based on the Th1/Th2
cytokine relationship. Infants are born with a dominant Th2
phenotype, and require interaction with beneficial
(microbiota) and pathogeneic organisms in order to
stimulate the Th1 immune response. Failure to do so is
associated with a Th2 dominance, which may result in
allergic disease, autoimmunity and cancers. Treg cells play
a central role in regulation and immune suppression.
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